| Bid | 0.32 |
| Market Cap | 5.62M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -0.9 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.33 |
| Volume | 264,472 |
| Avg. Volume (20D) | 952,850 |
| Open | 0.32 |
| Previous Close | 0.33 |
| Day's Range | 0.32 - 0.33 |
| 52-Week Range | 0.24 - 1.35 |
| Beta | undefined |
About BMRA
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies...
3 years ago · investorplace.com
Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to PopAccording to Fintel, here are five short squeeze stocks that are among the most likely to see a squeeze attempt moving forward. The post Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Thi...
3 years ago · investorplace.com
BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling TodayBiomerica (BMRA) stock is surging higher on Friday thanks to a new deal with Walmart (WMT) concerning its EZ Detect product. The post BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smil...
